Herceptin Biosimilar Market - (By Application - Breast Cancer, Colorectal Cancer, Leukemia, Lymphoma Market By End Users- Hospital & Clinics, Oncology Centers) - Global Industry Size, Share, Trends, and Forecast, 2018-2026

Category : Healthcare and Pharmaceuticals | Delivery Format: PDF | Status: Published | Pages : 150

CHAPTER 1. INDUSTRY OVERVIEW
 
1.1. Definition and Scope 
   1.1.1. Definition of Herceptin Biosimilar
   1.1.2. Market Segmentation
   1.1.3. List of Abbreviations
1.2. Summary
   1.2.1. Market Snapshot
   1.2.2. Herceptin Biosimilar Market By Application
         1.2.2.1. Global Herceptin Biosimilar Market Revenue and Growth Rate Comparison By Application (2015-2026)
         1.2.2.2. Global Herceptin Biosimilar Market Revenue Share By Application in 2017
         1.2.2.3. Breast Cancer
         1.2.2.4. Colorectal Cancer
         1.2.2.5. Leukemia
         1.2.2.6. Lymphoma
         1.2.2.7. Others
   1.2.3. Herceptin Biosimilar Market By End-User
         1.2.3.1. Global Herceptin Biosimilar Market Revenue and Growth Rate Comparison By End-User (2015-2026)
         1.2.3.2. Global Herceptin Biosimilar Market Revenue Share By End-User in 2017
         1.2.3.3. Hospital & Clinics
         1.2.3.4. Oncology Centers
         1.2.3.5. Others
   1.2.4. Herceptin Biosimilar Market by Geography
         1.2.4.1. Global Herceptin Biosimilar Market Revenue and Growth Rate Comparison by Geography (2015-2026)
         1.2.4.2. North America Herceptin Biosimilar Market Revenue and Growth Rate (2015-2026)
         1.2.4.3. Europe Herceptin Biosimilar Market Revenue and Growth Rate (2015-2026)
         1.2.4.4. Asia-Pacific Herceptin Biosimilar Market Revenue and Growth Rate (2015-2026)
         1.2.4.5. Latin America Herceptin Biosimilar Market Revenue and Growth Rate (2015-2026)
         1.2.4.6. Middle East and Africa (MEA) Herceptin Biosimilar Market Revenue and Growth Rate (2015-2026)
 
CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
 
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities 
2.4. Porter’s Five Forces Analysis
   2.4.1. Bargaining Power of Suppliers
   2.4.2. Bargaining Power of Buyers
   2.4.3. Threat of Substitute
   2.4.4. Threat of New Entrants
   2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
   2.6.1. Raw Material and Suppliers
   2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
   2.8.1. Player Positioning Analysis
   2.8.2. Key Strategies Adopted By Leading Players
 
CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
 
3.1. Capacity and Commercial Production Date of Global Herceptin Biosimilar Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Herceptin Biosimilar Major Manufacturers in 2017 
3.3. R&D Status and Technology Source of Global Herceptin Biosimilar Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Herceptin Biosimilar Major Manufacturers in 2017
 
CHAPTER 4. Herceptin Biosimilar MARKET By Application
 
4.1. Global Herceptin Biosimilar Revenue By Application
4.2. Breast Cancer
   4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Colorectal Cancer
   4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Leukemia
   4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Lymphoma
   4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.6. Others
   4.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   4.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
 
CHAPTER 5. Herceptin Biosimilar MARKET By End-User
 
5.1. Global Herceptin Biosimilar Revenue By End-User
5.2. Hospital & Clinics
   5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Oncology Centers
   5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Others
   5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
 
CHAPTER 6. NORTH AMERICA Herceptin Biosimilar MARKET BY COUNTRY
 
6.1. North America Herceptin Biosimilar Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2. North America Herceptin Biosimilar Market Revenue Share Comparison, 2015 & 2026 (%)
6.3. U.S.
   6.3.1. U.S. Herceptin Biosimilar Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   6.3.2. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
6.4. Canada
   6.4.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   6.4.2. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
6.5. Mexico 
   6.5.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   6.5.2. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
 
CHAPTER 7. EUROPE Herceptin Biosimilar MARKET BY COUNTRY
 
7.1. Europe Herceptin Biosimilar Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. Europe Herceptin Biosimilar Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. UK 
   7.3.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   7.3.2. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
7.4. Germany
   7.4.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   7.4.2. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
7.5. France
   7.5.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   7.5.2. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
7.6. Spain
   7.6.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   7.6.2. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
7.7. Rest of Europe
   7.7.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   7.7.2. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
 
CHAPTER 8. ASIA-PACIFIC Herceptin Biosimilar MARKET BY COUNTRY
 
8.1. Asia-Pacific Herceptin Biosimilar Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Asia-Pacific Herceptin Biosimilar Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. China 
   8.3.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   8.3.2. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
8.4. Japan 
   8.4.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   8.4.2. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
8.5. India 
   8.5.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   8.5.2. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
8.6. Australia 
   8.6.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   8.6.2. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
8.7. South Korea
   8.7.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   8.7.2. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
8.8. Rest of Asia-Pacific
   8.8.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   8.8.2. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
 
CHAPTER 9. LATIN AMERICA Herceptin Biosimilar MARKET BY COUNTRY 
 
9.1. Latin America Herceptin Biosimilar Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Latin America Herceptin Biosimilar Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. Brazil 
   9.3.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   9.3.2. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
9.4. Argentina 
   9.4.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   9.4.2. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
9.5. Rest of Latin America
   9.5.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
   9.5.2. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
 
CHAPTER 10. MIDDLE EAST Herceptin Biosimilar MARKET BY COUNTRY 
 
10.1. Middle East Herceptin Biosimilar Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Middle East Herceptin Biosimilar Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Saudi Arabia 
     10.3.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
     10.3.2. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
10.4. UAE 
     10.4.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
     10.4.2. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
10.5. Rest of Middle East 
     10.5.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
     10.5.2. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
 
CHAPTER 11. AFRICA Herceptin Biosimilar MARKET BY COUNTRY 
 
11.1. Africa Herceptin Biosimilar Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Africa Herceptin Biosimilar Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. South Africa
     11.3.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
     11.3.2. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
11.4. Egypt
     11.4.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
     11.4.2. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
11.5. Rest of Africa
     11.5.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
     11.5.2. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
 
CHAPTER 12. COMPANY PROFILE
 
12.1. Mylan
     12.1.1. Company Snapshot
     12.1.2. Overview
     12.1.3. Financial Overview
     12.1.4. Product Portfolio
     12.1.5. Key Developments
     12.1.6. Strategies
12.2. Biocon
     12.2.1. Company Snapshot
     12.2.2. Overview
     12.2.3. Financial Overview
     12.2.4. Product Portfolio
     12.2.5. Key Developments
     12.2.6. Strategies
12.3. Roche
     12.3.1. Company Snapshot
     12.3.2. Overview
     12.3.3. Financial Overview
     12.3.4. Product Portfolio
     12.3.5. Key Developments
     12.3.6. Strategies
12.4. Others
     12.4.1. Company Snapshot
     12.4.2. Overview
     12.4.3. Financial Overview
     12.4.4. Product Portfolio
     12.4.5. Key Developments
     12.4.6. Strategies
 
CHAPTER 13. RESEARCH APPROACH
 
13.1. Research Methodology
     13.1.1. Initial Data Search
     13.1.2. Secondary Research
     13.1.3. Primary Research
13.2. Assumptions and Scope

Cart Summary